Cable Viewer

Currently released so far... 12404 / 251,287

### Browse latest releases

2010/11 2010/12 2011/01 2011/02 2011/03 2011/04 2011/05
2010/11/28 2010/11/29 2010/11/30
2010/12/01 2010/12/02 2010/12/03 2010/12/04 2010/12/05 2010/12/06 2010/12/07 2010/12/08 2010/12/09 2010/12/10 2010/12/11 2010/12/12 2010/12/13 2010/12/14 2010/12/15 2010/12/16 2010/12/17 2010/12/18 2010/12/19 2010/12/20 2010/12/21 2010/12/22 2010/12/23 2010/12/24 2010/12/25 2010/12/26 2010/12/27 2010/12/28 2010/12/29 2010/12/30
2011/01/01 2011/01/02 2011/01/04 2011/01/05 2011/01/07 2011/01/09 2011/01/10 2011/01/11 2011/01/12 2011/01/13 2011/01/14 2011/01/15 2011/01/16 2011/01/17 2011/01/18 2011/01/19 2011/01/20 2011/01/21 2011/01/22 2011/01/23 2011/01/24 2011/01/25 2011/01/26 2011/01/27 2011/01/28 2011/01/29 2011/01/30 2011/01/31
2011/02/01 2011/02/02 2011/02/03 2011/02/04 2011/02/05 2011/02/06 2011/02/07 2011/02/08 2011/02/09 2011/02/10 2011/02/11 2011/02/12 2011/02/13 2011/02/14 2011/02/15 2011/02/16 2011/02/17 2011/02/18 2011/02/19 2011/02/20 2011/02/21 2011/02/22 2011/02/23 2011/02/24 2011/02/25 2011/02/26 2011/02/27 2011/02/28
2011/03/01 2011/03/02 2011/03/03 2011/03/04 2011/03/05 2011/03/06 2011/03/07 2011/03/08 2011/03/09 2011/03/10 2011/03/11 2011/03/13 2011/03/14 2011/03/15 2011/03/16 2011/03/17 2011/03/18 2011/03/19 2011/03/20 2011/03/21 2011/03/22 2011/03/23 2011/03/24 2011/03/25 2011/03/26 2011/03/27 2011/03/28 2011/03/29 2011/03/30 2011/03/31
2011/04/01 2011/04/02 2011/04/03 2011/04/04 2011/04/05 2011/04/06 2011/04/07 2011/04/08 2011/04/09 2011/04/10 2011/04/11 2011/04/12 2011/04/13 2011/04/14 2011/04/15 2011/04/16 2011/04/17 2011/04/18 2011/04/19 2011/04/20 2011/04/21 2011/04/22 2011/04/23 2011/04/24 2011/04/25 2011/04/26 2011/04/27 2011/04/28 2011/04/29 2011/04/30
2011/05/01 2011/05/02 2011/05/03 2011/05/04

### Browse by creation date

66 72 73 75 79 85 86 87 88 89 90 91 92 93 96 97 00 01 02 03 04 05 06 07 08 09 10
1966/12
1972/02 1972/08
1973/04
1975/03
1979/08
1985/03 1985/06
1986/05
1987/06
1988/01
1989/12
1990/01 1990/07 1990/08 1990/10
1991/05
1992/01 1992/06 1992/12
1993/10
1996/11
1997/12
2000/05 2000/06 2000/09 2000/11
2001/02 2001/03 2001/06 2001/07 2001/09 2001/10 2001/11
2002/01 2002/02 2002/03 2002/04 2002/07 2002/08 2002/09 2002/11
2003/01 2003/02 2003/03 2003/04 2003/05 2003/06 2003/07 2003/08 2003/09 2003/10 2003/11 2003/12
2004/01 2004/02 2004/03 2004/04 2004/05 2004/06 2004/07 2004/08 2004/09 2004/10 2004/11 2004/12
2005/01 2005/02 2005/03 2005/04 2005/05 2005/06 2005/07 2005/08 2005/09 2005/10 2005/11 2005/12
2006/01 2006/02 2006/03 2006/04 2006/05 2006/06 2006/07 2006/08 2006/09 2006/10 2006/11 2006/12
2007/01 2007/02 2007/03 2007/04 2007/05 2007/06 2007/07 2007/08 2007/09 2007/10 2007/11 2007/12
2008/01 2008/02 2008/03 2008/04 2008/05 2008/06 2008/07 2008/08 2008/09 2008/10 2008/11 2008/12
2009/01 2009/02 2009/03 2009/04 2009/05 2009/06 2009/07 2009/08 2009/09 2009/10 2009/11 2009/12
2010/01 2010/02

### Browse by origin

A B C D F G H I J K L M N O P Q R S T U V W Y Z
Embassy Athens Embassy Asuncion Embassy Astana Embassy Asmara Embassy Ashgabat Embassy Apia Embassy Ankara Embassy Amman Embassy Algiers Embassy Addis Ababa Embassy Accra Embassy Abuja Embassy Abu Dhabi Embassy Abidjan Consulate Auckland Consulate Amsterdam Consulate Adana American Institute Taiwan, Taipei
Embassy Bujumbura Embassy Buenos Aires Embassy Budapest Embassy Bucharest Embassy Brussels Embassy Bridgetown Embassy Bratislava Embassy Brasilia Embassy Bogota Embassy Bishkek Embassy Bern Embassy Berlin Embassy Belmopan Embassy Belgrade Embassy Beirut Embassy Beijing Embassy Banjul Embassy Bangkok Embassy Bandar Seri Begawan Embassy Bamako Embassy Baku Embassy Baghdad Consulate Barcelona
Embassy Copenhagen Embassy Conakry Embassy Colombo Embassy Chisinau Embassy Caracas Embassy Canberra Embassy Cairo Consulate Curacao Consulate Ciudad Juarez Consulate Chennai Consulate Casablanca Consulate Cape Town Consulate Calgary
Embassy Dushanbe Embassy Dublin Embassy Doha Embassy Djibouti Embassy Dili Embassy Dhaka Embassy Dar Es Salaam Embassy Damascus Embassy Dakar Consulate Dubai
Embassy Freetown
Embassy Guatemala Embassy Gaborone Consulate Guayaquil Consulate Guadalajara
Embassy Helsinki Embassy Harare Embassy Hanoi Consulate Ho Chi Minh City Consulate Hermosillo Consulate Hamilton Consulate Hamburg Consulate Halifax
Iran RPO Dubai Embassy Islamabad Consulate Istanbul
Embassy Jakarta Consulate Jerusalem Consulate Jeddah
Embassy Kyiv Embassy Kuwait Embassy Kuala Lumpur Embassy Kinshasa Embassy Kingston Embassy Kigali Embassy Khartoum Embassy Kathmandu Embassy Kampala Embassy Kabul Consulate Kolkata
Embassy Luxembourg Embassy Luanda Embassy London Embassy Ljubljana Embassy Lisbon Embassy Lima Embassy Lilongwe Embassy La Paz Consulate Lahore Consulate Lagos
Mission USOSCE Mission USNATO Mission UNESCO Embassy Muscat Embassy Moscow Embassy Montevideo Embassy Monrovia Embassy Minsk Embassy Mexico Embassy Mbabane Embassy Maputo Embassy Manila Embassy Manama Embassy Managua Embassy Malabo Embassy Madrid Consulate Munich Consulate Mumbai Consulate Montreal Consulate Monterrey Consulate Milan Consulate Melbourne
Embassy Nicosia Embassy New Delhi Embassy Ndjamena Embassy Nassau Embassy Nairobi Consulate Naples Consulate Naha
Embassy Ouagadougou Embassy Ottawa Embassy Oslo
Embassy Pristina Embassy Pretoria Embassy Prague Embassy Port Of Spain Embassy Port Louis Embassy Port Au Prince Embassy Phnom Penh Embassy Paris Embassy Paramaribo Embassy Panama Consulate Peshawar
Embassy Quito Consulate Quebec
REO Basrah Embassy Rome Embassy Riyadh Embassy Riga Embassy Reykjavik Embassy Rangoon Embassy Rabat Consulate Rio De Janeiro Consulate Recife
Secretary of State Embassy Suva Embassy Stockholm Embassy Sofia Embassy Skopje Embassy Singapore Embassy Seoul Embassy Sarajevo Embassy Santo Domingo Embassy Santiago Embassy Sanaa Embassy San Salvador Embassy San Jose Consulate Strasbourg Consulate St Petersburg Consulate Shenyang Consulate Shanghai Consulate Sao Paulo
Embassy Tunis Embassy Tripoli Embassy Tokyo Embassy The Hague Embassy Tel Aviv Embassy Tehran Embassy Tegucigalpa Embassy Tbilisi Embassy Tashkent Embassy Tallinn Consulate Toronto Consulate Tijuana
USUN New York USEU Brussels US Office Almaty US Mission Geneva US Interests Section Havana US Delegation, Secretary UNVIE Embassy Ulaanbaatar
Embassy Vilnius Embassy Vienna Embassy Vatican Embassy Valletta Consulate Vladivostok Consulate Vancouver
Embassy Windhoek Embassy Wellington Embassy Warsaw
Embassy Yerevan Embassy Yaounde
Embassy Zagreb

### Browse by tag

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
ASEC AE AF AM AR AJ AU AORC AG AEMR AMGT APER AGMT AL AFIN AO AMED ADCO AS ABUD ABLD ASUP ASECKFRDCVISKIRFPHUMSMIGEG APECO AID AND AMBASSADOR AN ARM AY AODE AMG ASCH AMCHAMS ARF APCS APEC ASEAN AGAO ANET ADPM ACOA ACABQ AORL AFFAIRS ATRN ACS AFSI AFSN ADANA ASIG AA AX AUC AC AECL AADP AGRICULTURE AMEX ACAO ACBAQ AQ AORG ADM AINF AIT ASEX AGR AROC ATFN AFGHANISTAN AFU AER ALOW AZ AVERY
BA BY BU BR BE BL BO BK BM BILAT BH BEXP BF BTIO BC BBSR BMGT BTIU BG BWC BB BD BX BP BRUSSELS BN BIDEN BT
CW CH CF CD CV CVIS CM CE CA CJAN CLINTON CIA CU CASC CI CO CACM CDB CN CMGT CS CG CBW CIS CR CONDOLEEZZA CPAS CAN CWC CY COUNTER CDG CL CT CIC CIDA CSW CHR CB CODEL COUNTERTERRORISM CTR COM CICTE CFED CJUS CKGR CBSA CEUDA CARSON CONS CITEL CLMT CROS CITT CAC CVR CDC CAPC COPUOS CBC CBE CARICOM COE COUNTRY CLEARANCE CACS CTM CNARC
DA DR DPRK DJ DEA DEPT DTRA DISENGAGEMENT DOD DEFENSE DOMESTIC DHS DAO DCM DO DE DEAX DOE DK DS
ECON EFIN ETRD EUN EFIS EG ETTC EZ EPET EAID EAGR ENRG ECUN EU ELAB ECPS EAIR EINV ELTN EWWT EIND EMIN EI ECIN ENVR ELECTIONS EINVEFIN EN ES ER EC EUC EINT EINVETC ENGR ET EK ENIV ETRDEINVECINPGOVCS ECONOMY EAP EFTA EUR EUMEM EXIM ERD ENERG EUREM ESA ERNG EXTERNAL EPA EINVECONSENVCSJA ECONOMICS ELN EINN EFINECONCS ENNP EEPET ETRDEINVTINTCS ENVI ETRO ESENV ECINECONCS ECONOMIC EAIDS EDU ETRA ETRN EFIM EIAR ETRC EAIG EXBS EURN ECIP EREL ECA ENGY ECONCS ECONEFIN ETC ETRDECONWTOCS EUNCH EINDETRD
FR FJ FI FREEDOM FTAA FARC FAO FINANCE FOR FO FDA FAC FM FTA FISO FMLN FBI FOREIGN FOI FAS FINR
GM GE GG GA GZ GV GH GT GR GY GAERC GOI GAZA GOV GTMO GL GLOBAL GTIP GCC GANGS GERARD GF
HO HURI HA HILLARY HR HU HUMOR HK HUMAN HSTC HEBRON HI HYMPSK
IR IZ IS IAEA INRB IRAJ IQ IN IT IMO INTERPOL ICAO IO IC ITALY ITALIAN IRAQI ICTY ID IPR IWC ILC INTELSAT IL IBRD IMF IA IRC ICRC ILO ITU ITRA IV IDA IAHRC ICJ ISRAELI IRS INMARSAT ISRAEL ISLAMISTS INDO IZPREL ITPHUM ITPGOV ITF IBET IEFIN INR IACI INTERNAL IDP IGAD IEA ICTR IIP INRA INRO IF
JO JA JAMES JM JP JOSEPH JOHNNIE JOHN JUS
KJUS KSCA KNNP KU KCOR KCRM KDEM KTFN KHLS KPAL KWBG KACT KGHG KPAO KTIA KIRF KWMN KS KG KZ KN KMDR KISL KSPR KHIV KPRP KAWK KR KUNR KDRG KCIP KGCC KTIP KSUM KPKO KVIR KAWC KPIN KGIC KRAD KIPR KOLY KCFE KMCA KE KV KICC KNPP KBCT KSEP KFRD KFLU KVPR KOCI KBIO KSTH KMPI KCRS KOMC KTBT KPLS KIRC KREL KFRDKIRFCVISCMGTKOCIASECPHUMSMIGEG KFLO KBTS KSTC KTDB KFSC KX KFTFN KNEI KIDE KREC KMRS KICA KPAONZ KCGC KSAF KRGY KCMR KRVC KVRP KSEO KCOM KAID KTEX KNUC KNAR KNUP KNNPMNUC KLIG KFRDCVISCMGTCASCKOCIASECPHUMSMIGEG KCRCM KHDP KGIT KNSD KOMS KWMM KPAI KHSA KTLA KO KMFO KRCM KCSY KSAC KTRD KPWR KID KWNM KRIM KPOA KCHG KOM KSCI KFIN KMOC KESS KWAC KMIG KSEC KIFR KDEMAF KPRV KBTR KERG KTER KDDG KPAK KRFD KHUM KDEV KCFC KWWMN KWMNCS KJUST
LE LY LG LU LH LI LO LOG LAB LTTE LA LABOR LT
MARR MOPS MU MTCRE MNUC MY MASS MCAP MOPPS MAR MPOS MO ML MR MASC MX MD MP MA MTRE MIL MCC MZ MK MDC MRCRE MAPS MV MI MEPN MAPP MEETINGS MAS MTS MLS MILI MTCR MG MC MARAD MIK MILITARY MEDIA MEPI MUCN MEPP MT MERCOSUR MW MASSMNUC MQADHAFI
NZ NATO NG NI NO NATIONAL NU NPT NIPP NL NPG NS NA NGO NP NSG NDP NAFTA NR NC NH NE NSF NPA NK NSSP NRR NATOPREL NSC NT NW NORAD NEW NV NSFO NAR NASA NZUS
OTRA OVIP OPRC OPDC OSCE OAS ODIP OIIP OFDP OVP OREP OFFICIALS OSAC OEXC OPCW OIE OIC OFDA OSCI OPIC OBSP OECD ON OCII OHUM OES OCS OMIG OPAD OTR
PGOV PREL PHUM PINR PTER PSOE PINS PARM PK PBTS PEPR PM POLITICAL PARTIES PREF PBIO PROP PA PSI PINT PO PKFK PL PAK PE POLITICS PINL POL PHSA PU PF POV PFOR PHALANAGE PARTY PARMS PRGOV PNAT POLINT PRAM PMAR PG PAO PROG PRELP PPA PCUL PSEPC PSA PREO PAHO PGIV PREFA PALESTINIAN PAIGH POSTS PTBS PGOVLO PORG PGOVE PLN PINF PAS PUNE POLICY PDEM PDOV PCI PGOVSMIGKCRMKWMNPHUMCVISKFRDCA PBT PHUMPGOV PMIL PNG PP PS PHUH PECON POGOV PY PHUMPREL PHUS PRL PGOC PNR PGGV PROV PTERE PGOF PHUMBA PEL
QA
RS RU RW REGION RP RICE ROBERT RSP RUPREL RM RO RCMP RSO RELATIONS REACTION REPORT RIGHTS ROOD RF RFE RIGHTSPOLMIL
SP SA SY SF SYR SENV SCUL SOCI SNAR SO SU SG STEINBERG SHUM SW SMIG SR SZ SIPRS SI SAARC SPCE SARS SN SYRIA SANC SL SCRS SC SENVKGHG SAN SNARCS SHI SWE SNARIZ SIPDIS SEN SNARN SPCVIS SEVN SSA SH SOFA SK ST
TPHY TU TRGY TI TX TS TW TC TFIN TD TSPA TH TT TIP TBIO TSPL TZ TERRORISM TRSY TN THPY TINT TF TL TV TK TO TP TURKEY TNGD TBID TAGS TR
UP US UNSC UK UZ UE UNESCO UV UNGA UN UNMIK UNO UY UAE UNEP UG UNHCR UNHRC USUN UNAUS USTR USNC USOAS UNCHR UNCSD UNDP USEU USPS UNDC UNDESCO UNCHC UNFICYP UNC UNODC UNPUOS UNCND UNICEF UNCHS UNVIE USAID UNIDROIT
VE VZ VN VT VTPREL VM VTIZ VTEG VI VAT VC
WTO WMO WI WTRQ WHO WWARD WA WB WBG WITH WTRO WHA WMD WIPO WS WZ WHTI WFP WEU
XF XA XL XM XR XS XT XK XY XC XG XW XD XV XX XB XE XZ XH XTAG XQ XU XI
YM YI YE YMCS
ZI ZP ZR ZF ZANU ZOELLICK ZU ZO ZB ZL ZK ZEALAND ZN ZA ZJ

### Browse by classification

CONFIDENTIAL CONFIDENTIAL//NOFORN SECRET SECRET//NOFORN UNCLASSIFIED UNCLASSIFIED//FOR OFFICIAL USE ONLY

### Community resources

Follow us on Twitter Check our Reddit Twitter this Digg this page Contact us on IRC

courage is contagious

### Viewing cable 08HELSINKI311, FINNISH GOVERNMENT APPROVES PHARMACEUTICAL

If you are new to these pages, please read an introduction on the structure of a cable as well as how to discuss them with others. See also the FAQs
Understanding cables
Every cable message consists of three parts:

- The top box shows each cables unique reference number, when and by whom it originally was sent, and what its initial classification was.
- The middle box contains the header information that is associated with the cable. It includes information about the receiver(s) as well as a general subject.
- The bottom box presents the body of the cable. The opening can contain a more specific subject, references to other cables (browse by origin to find them) or additional comment. This is followed by the main contents of the cable: a summary, a collection of specific topics and a comment section.

To understand the justification used for the classification of each cable, please use this WikiSource article as reference.
Discussing cables
If you find meaningful or important information in a cable, please link directly to its unique reference number. Linking to a specific paragraph in the body of a cable is also possible by copying the appropriate link (to be found at theparagraph symbol). Please mark messages for social networking services like Twitter with the hash tags #cablegate and a hash containing the reference ID e.g. #08HELSINKI311.

Reference ID | Created | Released | Classification | Origin
--- | --- | --- | --- | ---
08HELSINKI311 | 2008-07-09 09:09 | 2011-04-24 00:12 | UNCLASSIFIED | Embassy Helsinki

`

    VZCZCXYZ0002
    RR RUEHWEB

    DE RUEHHE #0311/01 1910935
    ZNR UUUUU ZZH
    R 090935Z JUL 08
    FM AMEMBASSY HELSINKI
    TO RUEHC/SECSTATE WASHDC 4415
    RUCPDOC/DEPT OF COMMERCE WASHDC
    INFO RUCNMEU/EU INTEREST COLLECTIVE
    RUEHNY/AMEMBASSY OSLO 4744

` `

    UNCLAS HELSINKI 000311

    SIPDIS

    E.O. 12958: N/A
    TAGS: ETRD FI PREL
    SUBJECT: FINNISH GOVERNMENT APPROVES PHARMACEUTICAL

    REFERENCE PRICING SYSTEM

    ¶1. Summary:  In a disappointing move and despite Embassy and
    industry efforts, the Finnish cabinet voted unanimously June
    25 to approve a reference pricing scheme for pharmaceuticals,
    a provision of which undermines the value of patent
    protection for medicines created and manufactured by U.S. and
    other pharmaceutical companies. Parliament is expected to
    approve the proposal at the end of the summer.  Despite the
    fact that the Ministry of Economy and Employment, the
    Ministry of Foreign Affairs and the Chancellor of Justice
    initially opposed the proposal and Prime Minister Vanhanen
    was equivocal, in the end all acquiesced and supported the
    Minister of Social Affairs and Health and the short-term
    attraction of an estimated 50 million euros annually in
    savings.  Embassy will engage key parliamentary figures in
    the next month to urge that the government develop a revised
    proposal that achieves their stated objective of containing
    health care costs but that will maintain the level of
    intellectual property protection that pharmaceutical
    companies have previously enjoyed in Finland and continue to
    enjoy elsewhere in the European Union.  If the proposal
    passes as written, post will consult with local U.S. industry
    and Washington to determine if a Special 301 listing is
    appropriate in the 2009 cycle.  End Summary.

    ----------
    Background
    ----------

    ¶2.  Product patents have been granted in Finland only since
    ¶1995.  As such, nearly all products on the Finnish market are
    still protected only by analoguous process patents.  Prior to
    2006, when Finland enacted the fix it is now proposing to
    withdraw, the level of protection for innovative medicines in
    Finland was among the lowest in the EU.  At that time,
    industry faced three major hurdles that taken together formed
    a perfect storm:  weak patent protection, liberal market
    authorization and mandatory generic substitution.

    --------------------------------------------- -------
    Finland Does the Right Thing But Then Changes Course
    --------------------------------------------- -------

    ¶3.  After much Industry and Embassy lobbying, in 2006, the
    Finnish government established criteria in Section 57(c) of
    its Medicines Act that excluded pharmaceutical products from
    generic reimbursement if they were protected by an analogus
    process patent in Finland and enjoyed valid patent protection
    in at least five other countries in the European Union.
    57(c) was the result of long negotiations and was seen by
    industry as a fair and equitable solution.  Indeed, it was
    used as an example for other countries, notably Norway, of
    the ideal legislative remedy.  Trouble started in the summer
    of 2007 when the Finnish Pharmaceutical Pricing Board (PPB)
    began cancelling the reimbursement status of some innovative
    drugs, claiming the PPB was bound only by the Health
    Insurance Act, not the the Medicines Act that contained the
    exclusion criteria. At first, Industry and Econoff believed
    this was an isolated action by an overzealous PPB chief,
    especially because when we raised it with the newly-installed
    Health Minister, she freely admitted she did not know what we
    were talking about.  Clearly she eventually got up to speed,
    because before long her ministry was overtly supporting the
    complete withdrawal of the 57(c) arrangement instead of
    supporting similar exclusion criteria for the Health
    Insurance Act as industry was proposing.

    ------------------------
    USG and Industry Efforts
    ------------------------

    ¶4. Beginning late last year, Econoff and Commercial Officer
    began working closely with the U.S. pharmaceutical company
    representatives here in Finland as well as with the local
    trade association Pharma Industry Finland (PIF) and its
    director, former Finance Minister Suvi-Anne Siimes to devise
    a strategy to head off the cancellation of 57(c).  Since
    January 2008 the Embassy has raised this at the highest level
    of Finnish government, including with the Prime Minister but
    also with virtually every other minister in the entire
    government.  Our strategy, carefully coordinated with
    industry and Washington, has focused on underscoring that
    Finland's knowledge-based economy has attracted much r&d
    investment, including health-related project funds from the
    USG.  A small IPR deficiency would undermine Finland's
    deserved reputation for innovation, a blow that was surely
    not worth the short-term gains from savings.  Industry
    reinforced this message during the visit of Alex Azar, Eli
    Lilly's Senior VP for Corporate Affairs (and a former Deputy
    Secretary of HHS) and through intensive lobbying by PIF and
    Siimes.  Siimes has also reached out to the German, French

    and Swiss Embassies whose companies also stand to suffer
    under the new arrangement.  USTR Ambassador Schwab and
    Secretary Gutierrez have written their Finnish counterparts
    on this issue and it has been raised with the Finnish Embassy
    in Washington and during the visits of high-level Finnish
    government officials.

    ----------
    Next Steps
    ----------

    ¶5.  With the cabinet's approval of the reference pricing
    scheme and the subsequent removal of the protection
    innovative products enjoyed under Section 57(c), there are
    few steps left.  Nonetheless, Embassy has a small window
    until the end of the summer when parliament will reconvene
    and consider the proposal.  Given that the MPs' party
    representatives in the cabinet have already approved the
    proposal, however, chances for success are slim.  However, we
    remain committed to raising this with parliamentary leaders
    in an attempt to encourage the development of a revised
    proposal.  If that fails, we will examine whether this
    unfortunate set of events merits Finland's inclusion on the
    Special 301 list.

    BUTLER

`